Tissue engineering of musculoskeletal tissues, especially bone and cartilage, is a quickly propelling field. In bone, innovation has fixated on bone unite substitute materials and the improvement of biodegradable scaffolds. Tissue engineering methodologies have included cell and gene therapy. The accessibility of development factors and the growing information base concerning the genetics and regulation of bone formation have generated new materials for tissue-engineering applications. The issues are more perplexing, and the solutions appear more elusive. Innovations in scaffold design and cell culture have improved the prognosis for success. A number of matrices have been tested in vitro and in vivo in preclinical and clinical examinations. These networks can be characterized by their nature.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy